These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36967262)

  • 21. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.
    McFadden EP; Stabile E; Regar E; Cheneau E; Ong AT; Kinnaird T; Suddath WO; Weissman NJ; Torguson R; Kent KM; Pichard AD; Satler LF; Waksman R; Serruys PW
    Lancet; 2004 Oct 23-29; 364(9444):1519-21. PubMed ID: 15500897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
    Kawashima H; Serruys PW; Ono M; Hara H; O'Leary N; Mack MJ; Holmes DR; Morice MC; Head SJ; Kappetein AP; Thuijs DJFM; Milojevic M; Noack T; Mohr FW; Davierwala PM; Sharif F; McEvoy JW; Onuma Y;
    J Am Coll Cardiol; 2021 Jul; 78(1):27-38. PubMed ID: 34210411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Platelet Reactivity and Intrastent Thrombi Assessed by OCT After DES.
    Fukuhara K; Okura H; Kume T; Yamada R; Neishi Y; Uemura S; Yoshida K
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):210-212. PubMed ID: 27085448
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of coronary angiography in patients with recurrent angina pectoris in long-term period after coronary artery bypass grafting].
    Aitkozhin GK; Ruslanuly K; Israilova VK; Krivolapova DA; Magauina AK; Kaliakbarova MZ; Bektemir AE
    Khirurgiia (Mosk); 2019; (8):36-40. PubMed ID: 31464272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
    Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy.
    Yahagi K; Virmani R; Kesavamoorthy B
    Cardiovasc Interv Ther; 2017 Jan; 32(1):53-55. PubMed ID: 26521263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful Prasugrel Therapy for Recurrent Left Main Stent Thrombosis in a Clopidogrel Hyporesponder.
    Kim YS; Lee SR
    Tex Heart Inst J; 2015 Oct; 42(5):483-6. PubMed ID: 26504448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
    Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet therapy after percutaneous coronary intervention.
    Holmes DR
    Cerebrovasc Dis; 2006; 21 Suppl 1():25-34. PubMed ID: 16479099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous very late stent thrombosis in multiple coronary arteries.
    Narasimhan S; Krim NR; Silverman G; Monrad ES
    Tex Heart Inst J; 2012; 39(5):630-4. PubMed ID: 23109755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study.
    Worthley SG; Abizaid A; Kirtane AJ; Simon DI; Windecker S; Brar S; Meredith IT; Shetty S; Sinhal A; Almonacid AP; Chamié D; Maehara A; Stone GW;
    JACC Cardiovasc Interv; 2017 Jan; 10(2):147-156. PubMed ID: 28104208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management.
    Lablanche JM; McFadden EP; Bonnet JL; Grollier G; Danchin N; Bedossa M; Leclercq C; Vahanian A; Bauters C; Van Belle E; Bertrand ME
    Eur Heart J; 1996 Sep; 17(9):1373-80. PubMed ID: 8880023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes with 6 months dual antiplatelet therapy after implantation of biolimus-A9 drug eluting coronary stents.
    Cockburn J; Pareek N; Poliacikova P; Saraf S; Williams R; Dhillon G; Robinson D; Gerber R; Hatrick R; Blows L; de Belder A; Hildick-Smith D
    Int J Cardiol; 2014 Mar; 172(1):185-9. PubMed ID: 24462139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stents.
    Kang SJ; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Shimizu T; Xu K; Kirtane AJ; Stone GW; Maehara A
    Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25552564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study.
    Witzenbichler B; Maehara A; Weisz G; Neumann FJ; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Stuckey TD; Mazzaferri EL; Xu K; Parise H; Mehran R; Mintz GS; Stone GW
    Circulation; 2014 Jan; 129(4):463-70. PubMed ID: 24281330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society.
    Fitchett D; Eikelboom J; Fremes S; Mazer D; Singh S; Bittira B; Brister S; Graham J; Gupta M; Karkouti K; Lee A; Love M; McArthur R; Peterson M; Verma S; Yau T
    Can J Cardiol; 2009 Dec; 25(12):683-9. PubMed ID: 19960127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
    Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subacute thrombosis after coronary stenting occurring with resistance to ticlopidine.
    Fuchigami S; Oshima S; Hokimoto S; Noda K; Fukushima H; Yoshida T; Takushi Y; Ogawa H
    Intern Med; 2006; 45(10):675-8. PubMed ID: 16778339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathologically confirmed very late stent thrombosis associated with stent fracture after implantation of first-generation drug eluting stent.
    Konishi T; Funayama N; Yamamoto T; Hotta D; Kobayashi Y; Komoriyama H; Kato Y; Omote K; Sato T; Kamiya K; Nagai T; Tanaka S; Anzai T
    Cardiol J; 2020; 27(2):204-205. PubMed ID: 32463109
    [No Abstract]   [Full Text] [Related]  

  • 40. Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents.
    Hermiller JB; Krucoff MW; Kereiakes DJ; Windecker S; Steg PG; Yeh RW; Cohen DJ; Cutlip DE; Massaro JM; Hsieh WH; Mauri L;
    JACC Cardiovasc Interv; 2016 Jan; 9(2):138-47. PubMed ID: 26793956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.